Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma

Show other versions (1)
Bibliographic Details
Main Authors: Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco‐Aparicio, Cristian Garcia‐Ruiz, Charlotte Welinder, Javanshir Esfandyari, Michael O'Neill, Joaquin Pastor, Kristoffer vonStedingk, Daniel Bexell
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:EMBO Molecular Medicine
Online Access:https://doi.org/10.15252/emmm.201911749

Internet

https://doi.org/10.15252/emmm.201911749

Similar Items